# Structure Therapeutics' Oral GLP-1 Shows 15% Weight Loss, Positioning It Against Eli Lilly and Novo Nordisk

- slug: structure-therapeutics-oral-glp-1-shows-15-weight-loss-positioning-it-against-eli-lilly-and-novo
- date: 2026-03-16
- category: Biotech & Life Sciences

**Aleniglipron data positions Structure as third player in race for oral obesity drugs**

---

In the heated race to develop oral GLP-1 drugs for obesity, a third contender is emerging.

Structure Therapeutics reported Phase 2 data this week for aleniglipron, its once-daily oral small molecule GL...

---